Acelrx pharmaceuticals announces upcoming podium presentation on use of dsuvia® for plastic surgery procedures at the aesthetic meeting 2022

Hayward, calif. , april 21, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), ("acelrx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced an upcoming podium presentation on dsuvia (sufentanil sublingual tablet, 30 mcg) which will be presented at the annual meeting of the aesthetic society®, "the aesthetic meeting 2022", held from april 20 -24 at the san diego convention center.
ACRX Ratings Summary
ACRX Quant Ranking